FIELD: medicine.
SUBSTANCE: invention relates to pharmaceutical composition, suitable for peroral introduction in form of solid medicinal form, which contains efficient amount of main salt of formula 
compound and composition with controlled rate of release, which contains solubilising agent, gel-forming agent and eater-soluble filler.
EFFECT: compositions are suitable for application in inhibiting of HIV integrase, treatment and prevention of HIV infection, and in treatment, prevention and retardation of AIDS development.
15 cl, 4 dwg, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING INTEGRASE INHIBITOR | 2010 |
|
RU2602865C2 |
| APPLICATION OF ATASANAVIR FOR IMPROVEMENT OF PHARMAKINETICS OF UGT1A1-METABOLISED MEDICATIONS | 2005 |
|
RU2403066C2 |
| PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL PREPARATION COMPRISING OXAPROZINE POTASSIUM, SODIUM AND TRIS SALTS, THEIR APPLICATION FOR PAIN RELIEF OR WEAKENING IN MAMMAL AND FOR TREATMENT OF INFLAMMATION AND DISORDERS ASSOCIATED WITH INFLAMMATION IN MAMMAL, METHOD OF PHARMACEUTICAL PREPARATION PREPARING | 1997 |
|
RU2197244C2 |
| DISPERSIBLE COMPOSITIONS | 2017 |
|
RU2826218C2 |
| COMPOSITION OF BIS-PHOSPHONIC ACIDS FOR WET GRANULATION | 1995 |
|
RU2149003C1 |
| STABLE PHARMACEUTICAL COMPOSITION OF WATER-SOLUBLE SALT OF VINORELBINE | 2008 |
|
RU2476208C2 |
| IRBESARTAN-CONTAINING PHARMACEUTICAL COMPOSITIONS | 1996 |
|
RU2181590C2 |
| COMBINATION, ITS APPLICATION AND METHODS FOR TREATMENT USING SPECIFIED COMBINATION | 2018 |
|
RU2755710C2 |
| PHARMACEUTICAL COMPOSITION BASED ON BENZODIAZEPINE AGONIST | 2004 |
|
RU2335288C2 |
| COMPOSITION FOR TREATING DISTURBED INNERVATION (VERSIONS) | 2013 |
|
RU2536269C1 |
